Overview

Study to Evaluate the Drug-drug Interaction of JMKX003142 in Healthy Subjects

Status:
NOT_YET_RECRUITING
Trial end date:
2025-03-21
Target enrollment:
Participant gender:
Summary
To evaluate the effects of oral administration rifampicin or itraconazole capsules on the pharmacokinetics of JMKX003142 in healthy subjects.
Phase:
PHASE1
Details
Lead Sponsor:
Jemincare
Collaborator:
Zhejiang Hangyu Pharmaceutical Co., Ltd.
Treatments:
Itraconazole
Rifampin